scorecardresearch
Add as a preferred source on Google
Wednesday, January 14, 2026
TopicSerum Institute India

Topic: Serum Institute India

How Serum Institute, DNDi tie-up for affordable antibody will bolster global fight against dengue

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'. 

Karan Johar’s studio sells 50% stake worth 10 bn rupees to vaccine maker Adar Poonawalla

SII CEO will buy stake through his production company, Serene Productions -- another major investment outside pharma sector after picking up 20% of social media platform Wakau Interactive in 2021.

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

On Camera

India’s nuclear-power goal needs more than capital

New Delhi has finally accepted that the base load power demand of the future will need supplementing, and nuclear plants are one way to go about it.

Coastal states Maharashtra, TN, Gujarat top India’s exports index, landlocked UP a surprise performer

Releasing Export Preparedness Index report, NITI Aayog CEO says Centre has ‘ticked a lot of boxes’, & responsibility of driving the next phase of export growth now rests with states.

Rafale deal to be inked in 2026, final assembly line in Nagpur, Indian firms to be roped in

The proposed project costing about Rs 3.25 lakh crore will entail procurement of 18 aircraft in fly away condition & the rest made in India with up to 60% indigenous content.

Thank you Donald Trump, again. India now has reason to shed fear of trade deals and risky reform

UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.